Cronos Group Stock News

Zacks Investment Research upgraded shares of Cronos Group (NASDAQ:CRON) from a hold rating to a buy rating in a research note published on Monday, Zacks.com reports. Zacks Investment Research currently has $5.50 price objective on the stock. According to Zacks, “Cronos Group, Inc. engages in the investment in firms which are licensed to produce and […]

Cronos Group (TSE:CRON)s stock had its underweight rating reissued by research analysts at Barclays in a research report issued on Tuesday, Analyst Price Targets reports. They currently have a C$5.00 price target on the stock. Barclayss price target points to a potential downside of 18.17% from the companys current price. A number of other equities []

Barclays reaffirmed their underweight rating on shares of Cronos Group (TSE:CRON) in a research note published on Tuesday, Analyst Ratings Network reports. Barclays currently has a C$5.00 target price on the stock. CRON has been the topic of a number of other reports. Canaccord Genuity cut their target price on Cronos Group from C$7.50 to []

Uber enters into cannabis space in Ontario, Canada by listing Tokyo Smoke in its marketplace. In today's episode we covered the following public companies:

Cronos Group (TSX: CRON) on Friday after hours provided a bi-weekly management cease trade update in connection with its delayed

Cryptocean (CURRENCY:CRON) traded 0.4% higher against the U.S. dollar during the 1 day period ending at 10:00 AM Eastern on November 21st. One Cryptocean coin can now be bought for approximately $2.10 or 0.00003559 BTC on popular cryptocurrency exchanges. Over the last seven days, Cryptocean has traded 2.2% lower against the U.S. dollar. Cryptocean has []

Barclays started coverage on shares of Cronos Group (NASDAQ:CRON) in a research report released on Thursday morning, The Fly reports. The brokerage issued an underweight rating and a $5.50 price objective on the stock. CRON has been the topic of several other research reports. Canaccord Genuity reduced their price objective on shares of Cronos Group []

Barclays started coverage on shares of Cronos Group (TSE:CRON) in a report published on Thursday morning, TipRanks reports. The brokerage issued a sell rating and a C$5.50 price objective on the stock. A number of other equities analysts have also recently issued reports on the stock. Canaccord Genuity cut their target price on shares of []

This article will guide you on how to bridge your funds from Binance Smart chain to Cronos mainnet for Agile Finance Private Sale. ELK Continue reading on Medium »

Bon Natural Life (NYSE:BON) and Cronos Group (NASDAQ:CRON) are both small-cap consumer discretionary companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, dividends, valuation, profitability, risk, earnings and institutional ownership. Insider & Institutional Ownership 0.1% of Bon Natural Life shares are held by []

TORONTO, Nov. 19, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 – Management Cease Trade Orders (“ NP 12-203 ”) and disclosing receipt of a Nasdaq Listing delinquency letter.

The CEOs of Akerna, Anacostia Organics, Bridge City Collective, Canopy Growth, Central Coast Agriculture, Columbia Care, Cresco Labs, Cronos Group, CULTA, Curaleaf, Flower One, Flowhub, Forian,…

An analyst initiated coverage on three of the stocks, but all of them fell as a result.

Barclays has issued a report that has cast doubt over an entire industry and has sent cannabis stocks plunging. Should you be worried?